KR20230018462A - 중쇄 트리글리세리드(triglyceride)를 사용한 영아 연축(infantile spasm)의 치료 방법 - Google Patents
중쇄 트리글리세리드(triglyceride)를 사용한 영아 연축(infantile spasm)의 치료 방법 Download PDFInfo
- Publication number
- KR20230018462A KR20230018462A KR1020227046044A KR20227046044A KR20230018462A KR 20230018462 A KR20230018462 A KR 20230018462A KR 1020227046044 A KR1020227046044 A KR 1020227046044A KR 20227046044 A KR20227046044 A KR 20227046044A KR 20230018462 A KR20230018462 A KR 20230018462A
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- day
- spasms
- administered
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- External Artificial Organs (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063032111P | 2020-05-29 | 2020-05-29 | |
| US63/032,111 | 2020-05-29 | ||
| US202163176747P | 2021-04-19 | 2021-04-19 | |
| US63/176,747 | 2021-04-19 | ||
| PCT/US2021/034883 WO2021243226A1 (en) | 2020-05-29 | 2021-05-28 | Methods for the treatment of infantile spasms using medium chain triglycerides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20230018462A true KR20230018462A (ko) | 2023-02-07 |
Family
ID=78744111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020227046044A Pending KR20230018462A (ko) | 2020-05-29 | 2021-05-28 | 중쇄 트리글리세리드(triglyceride)를 사용한 영아 연축(infantile spasm)의 치료 방법 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230181512A1 (https=) |
| EP (1) | EP4157250A4 (https=) |
| JP (1) | JP2023527454A (https=) |
| KR (1) | KR20230018462A (https=) |
| CN (1) | CN115884766A (https=) |
| AU (1) | AU2021281426A1 (https=) |
| CA (1) | CA3184353A1 (https=) |
| WO (1) | WO2021243226A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3595638A4 (en) * | 2017-03-15 | 2020-09-16 | Cerecin Inc. | PHARMACEUTICAL COMPOSITIONS WITH HIGH DRUG LOADS BASED ON MEDIUM-CHAIN TRIGLYCERIDES AND RELATED METHODS |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL164089A0 (en) * | 2002-04-30 | 2005-12-18 | Suntory Ltd | Astaxanthin medium-chain fatty acidester, production method of the same, and composition comprising the same |
| KR20070034591A (ko) * | 2004-06-17 | 2007-03-28 | 위스콘신 얼럼나이 리서어치 화운데이션 | 발작 및 발작병을 치료하기 위한 화합물 및 방법 |
| CA2882708A1 (en) * | 2012-08-21 | 2014-02-27 | Sage Therapeutics, Inc. | Methods of treating epilepsy or status epilepticus |
| US11331279B2 (en) * | 2014-05-29 | 2022-05-17 | Radius Pharmaceuticals, Inc. | Stable cannabinoid formulations |
| CA2986268C (en) * | 2015-05-28 | 2024-01-02 | Insys Development Company, Inc. | Stable cannabinoid formulations |
| EP3462885A4 (en) * | 2016-05-27 | 2020-01-22 | Insys Development Company, Inc. | STABLE CANNABINOID FORMULATIONS |
| EP3481387A4 (en) * | 2016-08-11 | 2020-04-08 | Ovid Therapeutics Inc | METHOD AND COMPOSITIONS FOR TREATING EPILEPTIC DISEASES |
| AU2017347778A1 (en) * | 2016-10-24 | 2019-05-16 | University Of South Florida | Delaying latency to seizure by combinations of ketone supplements |
| CN110678173B (zh) * | 2017-04-10 | 2023-03-28 | 维塔弗洛国际有限公司 | 用于治疗癫痫的组合物 |
| US10682317B2 (en) * | 2017-09-26 | 2020-06-16 | Zogenix International Limited | Ketogenic diet compatible fenfluramine formulation |
-
2021
- 2021-05-28 JP JP2022573444A patent/JP2023527454A/ja active Pending
- 2021-05-28 EP EP21813824.6A patent/EP4157250A4/en active Pending
- 2021-05-28 WO PCT/US2021/034883 patent/WO2021243226A1/en not_active Ceased
- 2021-05-28 AU AU2021281426A patent/AU2021281426A1/en active Pending
- 2021-05-28 CA CA3184353A patent/CA3184353A1/en active Pending
- 2021-05-28 CN CN202180038956.9A patent/CN115884766A/zh active Pending
- 2021-05-28 US US17/926,472 patent/US20230181512A1/en active Pending
- 2021-05-28 KR KR1020227046044A patent/KR20230018462A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN115884766A (zh) | 2023-03-31 |
| US20230181512A1 (en) | 2023-06-15 |
| CA3184353A1 (en) | 2021-12-02 |
| AU2021281426A1 (en) | 2023-02-02 |
| WO2021243226A1 (en) | 2021-12-02 |
| EP4157250A1 (en) | 2023-04-05 |
| JP2023527454A (ja) | 2023-06-28 |
| EP4157250A4 (en) | 2024-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2001293B1 (en) | Use of ketogenic compounds for treatment of age-associated memory impairment | |
| US20100261791A1 (en) | Compositions and Methods for Improving or Preserving Brain Function | |
| US20070135376A1 (en) | Method to reduce oxidative damage and improve mitochondrial efficiency | |
| US20180133190A1 (en) | Monoacylglycerols and fat-soluble nutrients for use in the treatment of nutrient deficiency from maldigestion | |
| US20060189545A1 (en) | Novel chemical entities and methods for their use in treatment of metabolic disorders | |
| KR20230018462A (ko) | 중쇄 트리글리세리드(triglyceride)를 사용한 영아 연축(infantile spasm)의 치료 방법 | |
| US20230346699A1 (en) | Administration of r-beta-hydroxybutyrate and related compounds in veterinary applications | |
| JP2016535037A (ja) | 非機械的基礎を有する吸収不良の処置における使用のためのモノアシルグリセロール及び脂溶性栄養素 | |
| US20240415793A1 (en) | Neuroprotective composition comprising pyruvate and citrate | |
| AU2022329943A1 (en) | Methods for the treatment of migraine and related headache symptoms using tricaprylin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| D21 | Rejection of application intended |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |